NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma
Yu Sun,1,* Yangshan Chen,1,* Shuhua Li,1,* Yiyan Lei,2 Di Xu,3 Neng Jiang,1 Yang Zhang,4 Jessica Cao,5 Zunfu Ke1,* 1Department of Pathology, 2Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China; 3...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f4cbf03adec641b4bad17b25fdddb3d5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f4cbf03adec641b4bad17b25fdddb3d5 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f4cbf03adec641b4bad17b25fdddb3d52021-12-02T07:21:41ZNanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma1178-2013https://doaj.org/article/f4cbf03adec641b4bad17b25fdddb3d52017-08-01T00:00:00Zhttps://www.dovepress.com/nanovelcro-captured-ctc-number-concomitant-with-enhanced-serum-levels--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yu Sun,1,* Yangshan Chen,1,* Shuhua Li,1,* Yiyan Lei,2 Di Xu,3 Neng Jiang,1 Yang Zhang,4 Jessica Cao,5 Zunfu Ke1,* 1Department of Pathology, 2Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China; 3Department of Thoracic Surgery, The Central Hospital of Wuhan, Wuhan, Hubei, People’s Republic of China; 4Biomedical Engineering, The University of Texas at El Paso, El Paso, TX, USA; 5Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada *These authors contributed equally to this work Abstract: Lung adenocarcinoma (LADC) is among the most malignant cancers that frequently develops micrometastases even in early stages of the disease. Circulating tumor cell (CTC) number, matrix metalloproteinase (MMP) 7, and MMP9 show great prospects as predictive biomarkers in many tumors. However, the interactions between these biomarkers and the molecular basis of their roles in the metastasis and prognosis of LADC remain unclear. The present study revealed that an elevated CTC count and overexpression of MMP7 and MMP9 correlate with metastasis and clinical progression in LADC patients (n=143). Furthermore, MMP7 and MMP9 upregulation facilitates LADC cell migration in vitro and enhances serum CTC levels in a xenograft mouse model. More importantly, receiver operating characteristic (ROC) curves and Kaplan–Meier analysis confirmed more accurate prediction of metastasis and overall survival (OS) with a combination panel of CTC, MMP7, and MMP9. Taken together, our data show, for the first time, the involvement of MMP7 and MMP9 in the release of CTCs into the peripheral blood, and our data reveal that CTC count and expression of MMP7 and MMP9 can be used together as an effective clinical prediction panel for LADC metastasis and prognosis. Keywords: lung adenocarcinoma, circulating tumor cell, MMP7/MMP9, metastasis, prognosis Sun YChen YLi SLei YXu DJiang NZhang YCao JKe ZDove Medical Pressarticlelung adenocarcinomacirculation tumor cellMMP7/MMP9metastasisprognosisMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 6399-6412 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
lung adenocarcinoma circulation tumor cell MMP7/MMP9 metastasis prognosis Medicine (General) R5-920 |
| spellingShingle |
lung adenocarcinoma circulation tumor cell MMP7/MMP9 metastasis prognosis Medicine (General) R5-920 Sun Y Chen Y Li S Lei Y Xu D Jiang N Zhang Y Cao J Ke Z NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma |
| description |
Yu Sun,1,* Yangshan Chen,1,* Shuhua Li,1,* Yiyan Lei,2 Di Xu,3 Neng Jiang,1 Yang Zhang,4 Jessica Cao,5 Zunfu Ke1,* 1Department of Pathology, 2Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China; 3Department of Thoracic Surgery, The Central Hospital of Wuhan, Wuhan, Hubei, People’s Republic of China; 4Biomedical Engineering, The University of Texas at El Paso, El Paso, TX, USA; 5Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada *These authors contributed equally to this work Abstract: Lung adenocarcinoma (LADC) is among the most malignant cancers that frequently develops micrometastases even in early stages of the disease. Circulating tumor cell (CTC) number, matrix metalloproteinase (MMP) 7, and MMP9 show great prospects as predictive biomarkers in many tumors. However, the interactions between these biomarkers and the molecular basis of their roles in the metastasis and prognosis of LADC remain unclear. The present study revealed that an elevated CTC count and overexpression of MMP7 and MMP9 correlate with metastasis and clinical progression in LADC patients (n=143). Furthermore, MMP7 and MMP9 upregulation facilitates LADC cell migration in vitro and enhances serum CTC levels in a xenograft mouse model. More importantly, receiver operating characteristic (ROC) curves and Kaplan–Meier analysis confirmed more accurate prediction of metastasis and overall survival (OS) with a combination panel of CTC, MMP7, and MMP9. Taken together, our data show, for the first time, the involvement of MMP7 and MMP9 in the release of CTCs into the peripheral blood, and our data reveal that CTC count and expression of MMP7 and MMP9 can be used together as an effective clinical prediction panel for LADC metastasis and prognosis. Keywords: lung adenocarcinoma, circulating tumor cell, MMP7/MMP9, metastasis, prognosis |
| format |
article |
| author |
Sun Y Chen Y Li S Lei Y Xu D Jiang N Zhang Y Cao J Ke Z |
| author_facet |
Sun Y Chen Y Li S Lei Y Xu D Jiang N Zhang Y Cao J Ke Z |
| author_sort |
Sun Y |
| title |
NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma |
| title_short |
NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma |
| title_full |
NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma |
| title_fullStr |
NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma |
| title_full_unstemmed |
NanoVelcro-captured CTC number concomitant with enhanced serum levels of MMP7 and MMP9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma |
| title_sort |
nanovelcro-captured ctc number concomitant with enhanced serum levels of mmp7 and mmp9 enables accurate prediction of metastasis and poor prognosis in patients with lung adenocarcinoma |
| publisher |
Dove Medical Press |
| publishDate |
2017 |
| url |
https://doaj.org/article/f4cbf03adec641b4bad17b25fdddb3d5 |
| work_keys_str_mv |
AT suny nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT cheny nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT lis nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT leiy nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT xud nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT jiangn nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT zhangy nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT caoj nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma AT kez nanovelcrocapturedctcnumberconcomitantwithenhancedserumlevelsofmmp7andmmp9enablesaccuratepredictionofmetastasisandpoorprognosisinpatientswithlungadenocarcinoma |
| _version_ |
1718399493886443520 |